Correlation Between Kalvista Pharmaceuticals and BioNTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kalvista Pharmaceuticals and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kalvista Pharmaceuticals and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kalvista Pharmaceuticals and BioNTech SE, you can compare the effects of market volatilities on Kalvista Pharmaceuticals and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kalvista Pharmaceuticals with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kalvista Pharmaceuticals and BioNTech.

Diversification Opportunities for Kalvista Pharmaceuticals and BioNTech

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Kalvista and BioNTech is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Kalvista Pharmaceuticals and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Kalvista Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kalvista Pharmaceuticals are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Kalvista Pharmaceuticals i.e., Kalvista Pharmaceuticals and BioNTech go up and down completely randomly.

Pair Corralation between Kalvista Pharmaceuticals and BioNTech

Given the investment horizon of 90 days Kalvista Pharmaceuticals is expected to generate 1.51 times more return on investment than BioNTech. However, Kalvista Pharmaceuticals is 1.51 times more volatile than BioNTech SE. It trades about 0.05 of its potential returns per unit of risk. BioNTech SE is currently generating about -0.02 per unit of risk. If you would invest  517.00  in Kalvista Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of  498.00  from holding Kalvista Pharmaceuticals or generate 96.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Kalvista Pharmaceuticals  vs.  BioNTech SE

 Performance 
       Timeline  
Kalvista Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kalvista Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
BioNTech SE 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BioNTech showed solid returns over the last few months and may actually be approaching a breakup point.

Kalvista Pharmaceuticals and BioNTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kalvista Pharmaceuticals and BioNTech

The main advantage of trading using opposite Kalvista Pharmaceuticals and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kalvista Pharmaceuticals position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.
The idea behind Kalvista Pharmaceuticals and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal